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Background: Cholecystectomy is associated with increased risks in patients with cirrhosis. The well-
established advantages of laparoscopic surgery may be offset by the increased risk for complications
relating particularly to portal hypertension and coagulopathy.
Methods: A systematic search was undertaken to identify studies comparing open cholecystectomy
(OC) and laparoscopic cholecystectomy (LC) in patients with cirrhosis. A meta-analysis was performed of
the available randomized controlled trials (RCTs).
Results: Forty-four studies were analysed. These included a total of 2005 patients with cirrhosis who
underwent laparoscopic (n = 1756) or open (n = 249) cholecystectomy, with mortality rates of 0.74% and
2.00%, respectively. A meta-analysis of three RCTs involving a total of 220 patients was conducted. There
was a reduction in the overall incidences of postoperative complications and infectious complications and
a shorter length of hospital stay in LC. However, frequencies of postoperative hepatic insufficiency did not
differ significantly.
Conclusions: There are few RCTs comparing OC and LC in patients with cirrhosis. These studies are
small, heterogeneous in design and include almost exclusively patients with Child–Pugh class A and B
disease. However, LC appears to be associated with shorter operative time, reduced complication rates
and reduced length of hospital stay.
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Introduction
Prevalences of gallstones in patients with cirrhosis are estimated at
29–46%1,2 and thus are three times as high as those in patients
without cirrhosis.3,4 In the non-cirrhotic population, laparoscopic
cholecystectomy (LC) appears to have substantial advantages over
conventional open cholecystectomy (OC) in terms of hospital
stay and convalescence, but not in mortality, complications and
operative time.5 However, in the era prior to LC, reported post-
operative mortality in patients with cirrhosis undergoing OC was
7.5–25.5%6–9 and patients with the most advanced liver disease
were at the greatest risk. Perhaps for this reason, the 1992 National
Institutes of Health (NIH) consensus statement on LC confirmed
that patients with end-stage cirrhosis of the liver with portal
hypertension were not candidates for LC. The first study to spe-
cifically report outcomes of LC in the presence of cirrhosis was
published in 1993,10 since when many case series and a few case–
control studies of this group of patients have emerged. Indeed, a
meta-analysis was published in 2003.11 Since then, the literature
on the topic has further expanded to include randomized con-
trolled trials (RCTs). This aim of this study was to systematically
review the current literature on LC in cirrhosis and to determine
whether there is indeed evidence to substantiate the contention
that OC should be used preferentially in the presence of cirrhosis.
This study was presented at the Third Biennial Congress of the Asian Pacific
Hepatopancreatobiliary Association, 27–30 September 2011, Melbourne,
Victoria.
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Materials and methods
Literature search strategy
Searches were conducted of PubMed, the MEDLINE database
from 1950 to the 25th week of 2011 and the EMBASE database
from January 1980 to the 25th week of 2011. The OVID search
engine (Version OvidSP_UI03.02.04.102; Ovid Technologies, Inc.,
New York, NY, USA) was used. The MESH/EmTree heading ‘liver
cirrhosis’ yielded 63 980 hits in MEDLINE and 83 677 hits in
EMBASE, and the search term ‘liver cirrhosis’ yielded 81 315 hits
in PubMed. The MESH/EmTree heading ‘cholecystectomy’
yielded 22 175 hits in MEDLINE and 28 624 hits in EMBASE, and
the search term ‘cholecystectomy’ yielded 27 705 hits in PubMed.
The results of these searches were combined in each database to
yield 246 articles in MEDLINE, 365 articles in EMBASE and 414
articles in PubMed.
Study selection
Study evaluation was performed by two of the reviewers (JML and
PDT). Articles were selected on the basis of three levels of screen-
ing12 summarized in Fig. 1. Studies were included regardless of
publication status, date of publication and number of partici-
pants. Studies published in languages other than English13–15 were
translated and the data extracted. Where similar data from the
same institution were published on more than one occasion,10,16,17
data from the most relevant publication were analysed. In many
of the case series of OC prior to the widespread availability of
endoscopic retrograde cholangiopancreatography (ERCP), many
patients underwent concomitant open procedures, particularly
bile duct exploration and drainage.6,8,18–22 Because the morbidity
associated with these additional open procedures might poten-
tially bias comparison with surgery in the laparoscopic era (in
which concomitant laparoscopic bile duct exploration was almost
never performed), the aforementioned studies were excluded
from analysis.
Data extraction
Each of these 44 articles were independently reviewed by two of
the authors (JML and PDT), who separately extracted data on the
following categories: dates over which the study was conducted;
numbers of patients in the OC and LC groups; age and sex of the
patients studied; causes of liver disease; severity of cirrhosis;23
indication(s) for cholecystectomy; mortality; morbidity; rate of
Potentially relevant studies identified
and screened for retrieval
 n = 414
Potentially relevant manuscripts
reviewed,
 n = 103
Final study population,
 n = 44
Study abstracts retrieved for more
detailed evaluation
 n = 94
Studies excluded n = 320
  Not relevant n = 180
  Not focused on
  cholecystectomy n = 67
  Basic science/animal n = 13
  Review article n = 49
  Editorial or letter n = 9
  Paediatric n = 2
Studies excluded n = 59
  Not relevant n = 39
  Additional surgery n = 7
  Ambiguity or absence of
  data n = 8
  Duplicate n = 3
  Meta-analysis or review
  n = 2
Studies added n = 9
  Bibliography review and
  cross-referencing
Figure 1 Flow chart showing the search strategy used to identify studies
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conversion to LC; operation times; blood loss; transfusion
requirements, and length of hospital stay (LoS). The extracted
data were then crosschecked by the two authors to rule out dis-
crepancy. In the event of disagreement, data were extracted by a
third reviewer (VWTL).
Study outcomes
The main outcomes analysed were the total numbers of patients
with cirrhosis undergoing OC and LC and the total number of
postoperative deaths in each group. When reported, the patients’
Child–Pugh23 status, age, sex and indication for surgery were
recorded. Mortality was described with respect to Child–Pugh
status when data were provided. All studies, irrespective of design,
were included for these outcomes. Total postoperative complica-
tion rate, postoperative infectious complication rate, postopera-
tive hepatic insufficiency and LoS were recorded for each study,
but a meta-analysis was performed only for the RCTs. The total
rate of postoperative complications was a composite outcome
measure of complications including pneumonia, wound infec-
tion, urinary tract infection, intra-abdominal abscess and perito-
nitis. The rate of postoperative hepatic insufficiency referred to a
composite of the reported incidences of episodes of unspecified
liver failure, ascites and encephalopathy. Because not all outcomes
were universally reported in each study, when the proportional
frequency of an outcome was reported, the denominator was
altered according to the number of patients in the studies report-
ing that outcome (i.e. the population at risk).
Statistical methods
Because of the heterogeneity of the studies selected and the fact
that most of them lacked a control group, no meta-analysis could
be carried out on the case series and case–control studies. Hence,
a descriptive analysis based on the patient pool comprising all of
the patients in each of the OC and LC groups was performed. For
the RCTs only, meta-analyses were performed using Revman 5.0
(Version 5.0.25 for Mac OS X; Nordic Cochrane Centre, Cochrane
Collaboration, Copenhagen, Denmark).24 For dichotomous out-
comes, the odds ratio (OR) was calculated with a 95% confidence
interval (CI) using the Mantel–Haenszel (M–H) method. For con-
tinuous outcomes, the mean difference (MD) and 95% CI were
calculated. A random effects model was used. The heterogeneity of
study results was assessed using the chi-squared test and the I2
statistic of inconsistency. Statistically significant heterogeneity was
defined as a P-value of <0.1 or an I2 statistic >50%.25
Study quality
The studies were assessed using the Oxford Centre for Evidence-
Based Medicine Level of Evidence Scale.26 The studies included in
the analysis constituted Level 3b or Level 4 evidence, with the
exception of the three RCTs, which constituted Level 1b evidence
(Table 1).
Results
Description of studies
The studies included in the systematic review are summa-
rized in Table 1. Forty-four studies were included in the
analysis.7,13,15,16,22,27–65 These included three RCTs comparing open
and laparoscopic surgery in cirrhosis,47,52,56 three case–control
studies22,29,37 and 38 case series.7,13,15,16,27,28,30–36,38–46,48–51,53–55,57–65 Two
RCTs comparing outcomes of conventional LC and LC performed
using the harmonic scalpel in cirrhotic patients were included.28,57
Only the outcomes of conventional LC from these studies were
analysed. Main outcome measures are summarized in Table 2.
Patient characteristics
The systematic review included data pertaining to 2005 patients
with cirrhosis undergoing laparoscopic (n = 1756) and open
(n = 249) cholecystectomy. Data pertaining to the demographics,
severity of chronic liver disease, proportion of patients with acute
cholecystitis and conversion rate are summarized in Table 2.
Mortality and complications
Mortality rates in LC and OC were 0.74% and 2.00%, respectively
(Table 2). All the deaths in the OC cohort were contributed from
a single study,7 which did not report Child–Pugh status. Studies of
LC in which mortality was stratified according to Child–Pugh
status were analysed, including data pertaining to 1328 patients
among whom six deaths were reported. Four of these patients had
Child–Pugh class C status and the remaining two had Child–Pugh
class A and class B status, respectively. Rates of overall complica-
tions, infectious complications and postoperative hepatic insuffi-
ciency in the LC and OC groups are summarized in Table 2.
Meta-analysis of RCTs
Outcomes for a total of 220 patients reported in the RCTs were
subjected to meta-analysis. No instances of mortality were
recorded in any RCT. There were reductions in the overall inci-
dence of postoperative complications (OR 0.25, 95% CI 0.07–
0.88) (Fig. 2a) and in the incidence of infectious complications in
LC (OR 0.23, 95% CI 0.10–0.56) (Fig. 2b), but the frequency of
postoperative hepatic insufficiency did not differ significantly
between LC and OC (OR 0.53, 95% CI 0.12–2.32) (Fig. 2c).
Length of hospital stay was substantially shorter in patients under-
going LC (MD - 3.31, 95% CI - 4.46 to - 2.16) (Fig. 2d). Statis-
tically significant heterogeneity was observed in the analyses of
rates of all postoperative complications (I2 = 75%), postoperative
hepatic insufficiency (I2 = 69%) and LoS (I2 = 69%), but not in the
infectious complications outcome (I2 = 0%). Given the small
number of studies, funnel plot analysis could not be used to
explore bias.66,67
Discussion
This systematic review addressed the issue of whether the prefer-
ential utilization of OC in cirrhotic patients, as suggested by the
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Table 1 Summary of studies included in this systematic review
Author(s) City of institution Year Study design Participants, n LC OC Level of evidencea
Angrisani et al.27 Naples 1997 RCS 31 31 0 4
Bende & Csiszar13 Budapest 1997 RCS 27 27 0 4
Bessa et al.28 Alexandria 2011 PCS 20 20 0 4
Bingener et al.65 San Antonio, TX 2008 RCS 99 99 0 4
Clark et al.64 Sydney, NSW 2001 RCS 25 25 0 4
Cobb et al.63 Charlotte, NC 2005 RCS 22 22 0 4
Cucinotta et al.16 Messina 2003 RCS 22 22 0 4
Curro et al.62 Messina 2005 RCS 42 42 0 4
D'Albuquerque et al.61 São Paulo, SP 1995 RCS 12 12 0 4
da Silveira60 Stanford, CA 2006 RCS 33 24 9 4
Delis et al.59 Miami, FL 2010 RCS 220 220 0 4
Dunnington et al.58 Tucson, AZ 1987 RCS 22 0 22 4
El Nakeeb et al.57 Mansoura 2010 PCS 60 60 0 4
El-Awadi et al.56 Mansoura 2009 RCT 110 55 55 1b
Fernandes et al.55 San Antonio, TX 2000 RCS 48 48 0 4
Fontes et al.15 Porto Alegre, RS 2002 RCS 10 10 0 4
Friel et al.54 Boston, MA 1999 RCS 30 30 0 4
Garrison et al.7 Louisville, KY 1984 RCS 29 0 29 4
Gugenheim et al.53 Nice 1996 RCS 9 9 0 4
Hamad et al.52 Assiut 2010 RCT 30 15 15 1b
Hamid et al.51 Karachi 1993 RCS 18 0 18 4
Ishikawa et al.50 Osaka 1995 RCS 4 4 0 4
Jan & Chen49 Chang Gung 1997 RCS 21 21 0 4
Ji et al.48 Nanjing 2004 RCS 38 38 0 4
Ji et al.47 Nanjing 2005 RCT 80 42 38 1b
Kogut et al.46 New York, NY 1985 RCS 27 0 27 4
Lacy et al.45 Barcelona 1995 RCS 11 11 0 4
Leandros et al.44 Athens 2008 RCS 34 34 0 4
Leone et al.43 Turin 2001 RCS 24 24 0 4
Mancero et al.42 São Paulo, SP 2008 RCS 30 30 0 4
Morino et al.41 Turin 2000 RCS 33 33 0 4
Nguyen et al.40 Pittsburgh, PA 2011 RCS 68 68 0 4
Palanivelu et al.39 Tamilnadu 2006 RCS 265 265 0 4
Pavlidis et al.38 Thessaloniki 2009 RCS 38 38 0 4
Poggio et al.22 Rochester, MN 2000 RCC 36 24 12 3b
Saeki et al.37 Fukuoka 1997 RCC 13 7 6 3b
Schiff et al.36 Boston, MA 2005 RCS 31 27 4 4
Shaikh & Muneer35 Sindh 2009 RCS 20 20 0 4
Sleeman et al.34 Miami, FL 1998 RCS 25 25 0 4
Tuech et al.33 Angers 2002 RCS 26 26 0 4
Urban et al.32 Cleveland, OH 2001 RCS 15 15 0 4
Van Landingham31 Temple, TX 1984 RCS 7 ND 7 4
Yeh et al.30 Taoyuan 2002 RCS 226 226 0 4
Yerdel et al.29 Ankara 1997 PCC 14 7 7 3b
aOxford Centre for Evidence-Based Medicine level of evidence scale.
LC, laparoscopic cholecystectomy; OC, open cholecystectomy; RCS, retrospective case series; PCC, prospective case–control study;
RCC, retrospective case–control study; RCT, randomized controlled trial; PCS, prospective case series; ND, no data.
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1992 NIH consensus statement,68 has an impact on surgical out-
comes. There are few data pertaining to patients with Child–Pugh
class C cirrhosis; however, the review and meta-analysis shows
that for patients of Child–Pugh class A or B status, LC appears to
be associated with reduced complication rates, shorter operative
time and reduced LoS. In 1982 Aranha et al. described a 25.5%
mortality rate in patients with cirrhosis undergoing cholecystec-
tomy.9 During the dissemination of LC technique, concern about
the safety of the procedure in cirrhosis was coloured by such data
from the era of open surgery. Certainly, patients with chronic liver
disease are at increased risk for mortality when undergoing
abdominal surgery.69–71 Cholecystectomy in particular may be
more hazardous in cirrhosis because of haemorrhage related to
portal hypertension, coagulopathy and thrombocytopenia. In
addition, the reduced compliance of the fibrotic liver may make
the retraction and exposure of Calot’s triangle more difficult lap-
aroscopically.72 It was therefore posited that the benefits of laparo-
scopic surgery in terms of postoperative recovery5 would be offset
by the greater risk for complications associated with the lesser
degree of tactile control73 and three-dimensional feedback.74
The quality of the evidence comparing the outcomes of LC and
OC is poor. The majority of the data are derived from case series;
only three small RCTs have been published. In this systematic
review, the data from all studies were pooled as if the combined
findings were derived from a single sample, but statistical analyses
were not applied. The application of any formal meta-analytic
methods, particularly simple pooling, to observational studies is
associated with a significant risk for error and for biased conclu-
sions, but it does provide an indication of real-world outcomes.75
Given that combining data by meta-analytic methods is prefer-
able,76 only data from the RCTs were combined. However, it must
be acknowledged that the RCTs included in this review each
include a small number of patients and, indeed, heterogeneity is
evident in meta-analytic statistical measures (I2 statistic). This
heterogeneity is probably attributable to differences in the patient
samples (such as in the severity of liver disease and the proportion
of patients with acute cholecystitis), interventions (use of subtotal
cholecystectomy and conversion to OC), outcome assessments
and reporting quality. Despite the aforementioned caveats, it
appears that LC offers the cirrhotic patient a similar advantage
over OC in terms of LoS as it does the non-cirrhotic patient.5 In
contradistinction to the non-cirrhotic population undergoing
cholecystectomy, this meta-analysis suggests that overall compli-
cations and infectious complications may be fewer in LC than in
OC in cirrhosis.
Given that conversion to OC is always an option, LC in cirrhosis
should be at least as safe as ab initio open surgery provided that
the surgeon who starts the procedure laparoscopically has a range
of safe options available if problems arise intraoperatively. Com-
monly discussed options include laparoscopic subtotal39,77–79 and
partial80 cholecystectomy, which have been used successfully to
circumvent the hazards associated with dissection in the cirrhotic
liver bed and around the porta hepatis. Other options include
laparoscopic cholecystostomy81 and percutaneous transhepatic
cholecystostomy.82,83 Ultimately, conversion to an open procedure
remains a fall-back option when safe dissection, visualization of
anatomy or control of haemorrhage become impossible laparo-
scopically. In this review, conversion from LC represented a rea-
sonably frequently used option and occurred in about 5% of
procedures. Although an increase in morbidity may be associated
with the occasional conversion to open surgery compared with
cases completed laparoscopically,84 it seems intuitive that this
morbidity will be lower than that caused by a policy of universal
OC ab initio, provided that minimal complications arise in the
preliminary laparoscopic dissection.
In the current analysis, the mortality rates reported for both LC
and OC are substantially lower than those reported for OC in the
1980s. This probably reflects improvements in patient selection
and critical care, better treatment of liver failure (particularly liver
transplantation), and the availability of a variety of non-surgical
Table 2 Summary of outcome measures for laparoscopic and open cholecystectomy in cirrhosis
Outcome Laparoscopic cholecystectomy Open cholecystectomy
Number of patients 1756 249
Mortality rate, % (deaths/number at risk) 0.8% (13/1623) 2.0% (5/249)
Stratified mortalitya (A/B/C) 4/1/1 ND
Mean age  SE, years 52.6  1.2 50.2  3.2
Sex, male/female 804/759 103/67
Severity of liver diseasea, Child–Pugh class A/B/C 915/260/19 117/50/7
Indication for surgery, % AC (number AC/number at risk) 19.6% (283/1442) 28.8% (19/66)
Conversion rate, % (conversion/number at risk) 5.8% (98/1698) ND
Overall complications, % (events/number at risk) 17.6% (304/1729) 47.7% (103/216)
Infectious complications, % (events/number at risk) 5.9% (100/1729) 19.9% (43/216)
Postoperative hepatic insufficiency, % (events/number at risk) 7.7% (133/1729) 18.1% (39/216)
aChild–Pugh status stratified as A/B/C.
SE, standard error; AC, acute cholecystitis; ND, no data.
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options (such as percutaneous cholecystostomy and ERCP) for the
high-risk cirrhotic patient. There are relatively few data about the
outcome of cholecystectomy in Child–Pugh class C cirrhosis as
only 26 patients with this disease class were included in this review,
but this group was over-represented amongst the mortalities.
Although mortality rates as high as 25% were reported for OC in
cirrhosis as recently as the 1980s,9 this analysis of the literature
found no reports of death in OC in the cirrhotic population during
the era of LC. Clearly, therefore, the dramatic reduction in mortal-
ity in cholecystectomy in cirrhosis after LC became commonplace
was not associated with the introduction of minimally invasive
surgery, but, rather, with other changes in the assessment and
management of both chronic liver disease and gallstones. Previ-
ously, a considerable proportion of patients with significant jaun-
dice underwent OC and, subsequently, open bile duct exploration
and drainage procedures. Often these explorations were not thera-
peutic as the jaundice was presumably related to the decompensa-
tion of chronic liver disease and not obstruction.6,8,18–22 This type of
scenario has become uncommon since the accuracy of imaging85,86
and efficacy of endoscopic intervention87,88 have improved and
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Figure 2 Forest plots illustrating meta-analyses of outcomes in patients with cirrhosis undergoing cholecystectomy by laparoscopic or open
surgery. Outcomes analysed were: (a) total postoperative complications, (b) infectious complications, (c) postoperative hepatic insufficiency
and (d) length of hospital stay. M–H, Mantel–Haenszel test; 95% CI, 95% confidence interval
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percutaneous biliary interventions have become available.83,89,90
More generally, the death rate from chronic liver disease has
changed substantially coincident with the introduction of LC.91,92
Moreover, a significant proportion of the change in mortality in
patients with chronic liver disease undergoing surgery is likely to be
attributable to the widespread introduction of liver transplanta-
tion in the mid-1980s93 and the impact this has had on techniques
for managing liver failure and portal hypertension. The greatest
danger of mortality in cholecystectomy refers to patients with
decompensated liver disease. The most critical factors in avoiding
death are, therefore, appropriate diagnosis and treatment of the
underlying chronic liver disease, judicious selection of patients for
surgery and use of non-surgical temporization measures for
patients in whom the level of risk prohibits operative procedures.
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